Compare SHASUN PHARMA with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA PROCTER & GAMBLE HEALTH SHASUN PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 123.9 52.0 238.2% View Chart
P/BV x 8.5 4.7 181.2% View Chart
Dividend Yield % 0.2 10.1 2.3%  

Financials

 SHASUN PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
PROCTER & GAMBLE HEALTH
Dec-18
SHASUN PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs943,549 2.7%   
Low Rs461,301 3.5%   
Sales per share (Unadj.) Rs214.2511.4 41.9%  
Earnings per share (Unadj.) Rs5.361.3 8.7%  
Cash flow per share (Unadj.) Rs15.874.0 21.4%  
Dividends per share (Unadj.) Rs1.00440.00 0.2%  
Dividend yield (eoy) %1.418.1 7.9%  
Book value per share (Unadj.) Rs53.3927.8 5.7%  
Shares outstanding (eoy) m56.6216.60 341.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.34.7 6.9%   
Avg P/E ratio x13.139.6 33.1%  
P/CF ratio (eoy) x4.432.8 13.5%  
Price / Book Value ratio x1.32.6 50.1%  
Dividend payout %18.7717.9 2.6%   
Avg Mkt Cap Rs m3,95840,257 9.8%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m2,1641,313 164.8%   
Avg. sales/employee Rs ThNM7,486.7-  
Avg. wages/employee Rs ThNM1,157.6-  
Avg. net profit/employee Rs ThNM897.2-  
INCOME DATA
Net Sales Rs m12,1278,490 142.8%  
Other income Rs m229244 94.0%   
Total revenues Rs m12,3568,734 141.5%   
Gross profit Rs m1,0091,482 68.1%  
Depreciation Rs m594211 281.1%   
Interest Rs m4150-   
Profit before tax Rs m2301,514 15.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m-73563 -12.9%   
Profit after tax Rs m3021,017 29.7%  
Gross profit margin %8.317.5 47.7%  
Effective tax rate %-31.737.1 -85.2%   
Net profit margin %2.512.0 20.8%  
BALANCE SHEET DATA
Current assets Rs m6,88415,343 44.9%   
Current liabilities Rs m8,4561,960 431.4%   
Net working cap to sales %-13.0157.6 -8.2%  
Current ratio x0.87.8 10.4%  
Inventory Days Days6249 126.5%  
Debtors Days Days10828 378.1%  
Net fixed assets Rs m4,9701,209 411.0%   
Share capital Rs m113166 68.3%   
"Free" reserves Rs m2,87515,235 18.9%   
Net worth Rs m3,02015,401 19.6%   
Long term debt Rs m1,8170-   
Total assets Rs m13,34717,595 75.9%  
Interest coverage x1.6NM-  
Debt to equity ratio x0.60-  
Sales to assets ratio x0.90.5 188.3%   
Return on assets %5.45.8 92.9%  
Return on equity %10.06.6 151.4%  
Return on capital %13.310.3 129.9%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,8431,636 357.1%   
Fx outflow Rs m2,1734,368 49.7%   
Net fx Rs m3,669-2,732 -134.3%   
CASH FLOW
From Operations Rs m398-1,304 -30.5%  
From Investments Rs m-1,63512,697 -12.9%  
From Financial Activity Rs m1,309-301 -435.5%  
Net Cashflow Rs m7111,093 0.6%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 3.6 18.2 19.8%  
FIIs % 17.6 1.0 1,760.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 29.1 136.1%  
Shareholders   20,750 28,591 72.6%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   STRIDES PHARMA SCIENCE  AJANTA PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - TORRENT PHARMA COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS